Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioSolution Designs is a private biotechnology invention studio and intellectual property holding company focused on synthetic biology and multigenic advanced therapies. The company develops enabling technologies to create, control, deliver, and manufacture complex multigene constructs, and it commercializes these capabilities through internal R&D, research biotools, and spinout companies. Its platform stack spans gene delivery, genome context, gene expression control, effector engineering, and biomanufacturing, with Bird of Prey highlighted as a foundational DNA design and assembly platform. BioSolution Designs is using these technologies to support programs in cardiovascular, neurodegenerative, musculoskeletal, oncology, and rare disease settings, while also building affiliated entities such as BeatBio, Falcon, Multigenix, Condor, IntegrigEn, PeregrinE, and Osprey Bio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioSolution Designs.